13048_2019_590_MOESM2_ESM.docx (61.27 kB)
MOESM2 of Thy-1 predicts poor prognosis and is associated with self-renewal in ovarian cancer
journal contribution
posted on 2019-11-18, 04:18 authored by Elizabeth Connor, Caner Saygin, Chad Braley, Andrew Wiechert, Sheelarani Karunanithi, Katie Crean-Tate, Fadi Abdul-Karim, Chad Michener, Peter Rose, Justin Lathia, Ofer ReizesAdditional file 2: Figure S2. Thy-1 knockdown is effective in TOV211D ovarian cancer cells. Non-targeting control (sh002) and two knockdowns were generated and validated with TOV211D ovarian cancer cells via qRT-PCR (Figure S2A) and Western Blot (Figure S2B).
